ScholarIQanswers from OpenAlex

Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway

PaperCitations, authors & open-access status

Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway have?

ScholarIQcitation count

Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway has 6 citations in the OpenAlex counts ScholarIQ stores.

When was Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway published?

ScholarIQyear

Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway has 2023 year in the ScholarIQ index.

What is the open-access status of Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway?

ScholarIQoa status

Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway has closed oa status in the ScholarIQ index.

What is the DOI of Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway?

ScholarIQdoi

The DOI for Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway is on the source record.

What is the PMID of Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway?

ScholarIQpmid

The PMID for Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway is on the source record.

What is the OpenAlex record for Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway?

ScholarIQopenalex

The OpenAlex for Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cellsby Regulating the AKT/FOXO1 Pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial